Molecular prospect of type-2 diabetes: Nanotechnology based diagnostics and therapeutic intervention.
Rout George KerryGyana Prakash MahapatraGanesh Kumar MauryaSushmita PatraSubhasis MahariGitishree DasJayanta Kumar PatraSabuj SahooPublished in: Reviews in endocrine & metabolic disorders (2020)
About ninety percent of all diabetic conditions account for T2D caused due to abnormal insulin secretion/ action or increased hepatic glucose production. Factors that contribute towards the aetiology of T2D could be well explained through biochemical, molecular, and cellular aspects. In this review, we attempt to explain the recent evolving molecular and cellular advancement associated with T2D pathophysiology. Current progress fabricated in T2D research concerning intracellular signaling cascade, inflammasome, autophagy, genetic and epigenetics changes is discretely explained in simple terms. Present available anti-diabetic therapeutic strategies commercialized and their limitations which are needed to be acknowledged are addressed in the current review. In particular, the pre-eminence of nanotechnology-based approaches to nullify the inadequacy of conventional anti-diabetic therapeutics and heterogeneous nanoparticulated systems exploited in diabetic researches are also discretely mentioned and are also listed in a tabular format in the review. Additionally, as a future prospect of nanotechnology, the review presents several strategic hypotheses to ameliorate the austerity of T2D by an engineered smart targeted nano-delivery system. In detail, an effort has been made to hypothesize novel nanotechnological based therapeutic strategies, which exploits previously described inflammasome, autophagic target points. Utilizing graphical description it is explained how a smart targeted nano-delivery system could promote β-cell growth and development by inducing the Wnt signaling pathway (inhibiting Gsk3β), inhibiting inflammasome (inhibiting NLRP3), and activating autophagic target points (protecting Atg3/Atg7 complex from oxidative stress) thereby might ameliorate the severity of T2D. Additionally, several targeting molecules associated with autophagic and epigenetic factors are also highlighted, which can be exploited in future diabetic research.
Keyphrases
- signaling pathway
- cell death
- type diabetes
- wound healing
- oxidative stress
- pi k akt
- current status
- induced apoptosis
- stem cells
- cancer therapy
- randomized controlled trial
- dna methylation
- gene expression
- small molecule
- metabolic syndrome
- dna damage
- genome wide
- adipose tissue
- drug delivery
- endoplasmic reticulum stress
- weight loss
- heat shock
- ischemia reperfusion injury
- heat shock protein